
Standardizing Seventy Years of Messy Medical Data
The federal government is trying to force seven decades of incompatible medical research into a single format that artificial intelligence can actually understand.
Discover the newest research about AI innovations in 👤 Personalized Medicine.

The federal government is trying to force seven decades of incompatible medical research into a single format that artificial intelligence can actually understand.

An AI trained only on medical records managed to map the genetic drivers of human disease.

Predictive algorithms can now spot type 2 diabetes risk ten years in advance, but the real bottleneck is how healthcare systems will handle millions of newly flagged patients.

A patient’s fate is often hidden in the messy paragraphs of their medical charts rather than their official disease stage.

A new clinical deployment in California is putting AI-driven embryo selection to its first real-world test.

Measuring a single protein has been the gold standard for tracking ALS, but a new multi-protein signature suggests we have been missing the bigger biological picture.

A new multi-center model uses basic clinical data to flag brain metastasis before symptoms appear, challenging the need for expensive, complex biomarkers.

A new machine learning model proves we do not need expensive imaging or complex protein tracking to find patients whose knee pain will soon spike.

A new nine-protein blood signature outperforms traditional clinical models and single-marker tests in predicting how fast ALS progresses.

A new commercial retinal implant challenges the boundary between biological sight and digital translation, forcing healthcare to rethink how we treat blindness.